General Information of the Compound
| Compound ID |
CP0377505
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
5-[2-[(2R)-6-(5-cyclobutyloxy-2-fluorophenyl)-3,4-dihydro-2H-chromen-2-yl]ethyl]-2H-tetrazole
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C22H23FN4O2
|
||||||||||||||||||
| Molecular Weight |
394.45
|
||||||||||||||||||
| Canonical SMILES |
Fc1ccc(OC2CCC2)cc1-c1ccc2O[C@@H](CCc3nnn[nH]3)CCc2c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C22H23FN4O2/c23-20-9-7-18(28-16-2-1-3-16)13-19(20)14-5-10-21-15(12-14)4-6-17(29-21)8-11-22-24-26-27-25-22/h5,7,9-10,12-13,16-17H,1-4,6,8,11H2,(H,24,25,26,27)/t17-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
QRCVDJCVCCXOGB-QGZVFWFLSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02793, Free fatty acid receptor 1
Protein ID: PT04427, Free fatty acid receptor 4